Straits Times Index
3,290.70 +24.75 (+0.76%) Nikkei
38,229.11 +155.13 (+0.41%) Hang Seng
18,963.68 +425.87 (+2.30%) FTSE 100
8,433.76 +52.41 (+0.63%) Bitcoin USD
60,603.22 -1,563.45 (-2.51%) CMC Crypto 200
1,255.04 -102.96 (-7.58%)
GSK Nov 2024 44.000 call
| Previous close | 2.8500 |
| Open | 3.3000 |
| Bid | 3.2000 |
| Ask | 3.3000 |
| Strike | 44.00 |
| Expiry date | 2024-11-15 |
| Day's range | 3.2000 - 3.3000 |
| Contract range | N/A |
| Volume | |
| Open interest | 409 |
Simply Wall St.GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
GSK plc's ( LON:GSK ) investors are due to receive a payment of £0.15 per share on 11th of July. The dividend yield...
GlobeNewswireBioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C financing round extended overall by CHF 12.3 million to CHF 44.9 million BASEL, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- BioVersys AG, a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections
Insider MonkeyGSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript
GSK plc (NYSE:GSK) Q1 2024 Earnings Call Transcript May 4, 2024 GSK plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Nick Stone: Hello everyone. Welcome to today’s call and webcast. The presentation was sent to our distribution list by email, and […]
